Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis
International Journal of Molecular Sciences · 11.08.2026 · 27 (16) · 7159
DOI: 10.3390/ijms27167159 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.08.2026. Verfasst von Lifang Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Osteoimmunology & Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 D…. Hauptthemen laut MEDLINE: Osteoclasts, RANK Ligand, NFATC Transcription Factors, Cell Differentiation. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou-Kean University, International Frontier Interdisciplinary Research Institute of Wenzhou-Kean University, the WKU-ISRG.
Abstract (Originalsprache)
Excessive osteoclast formation is a key contributor to pathological bone loss in disorders such as osteoporosis and rheumatoid arthritis. Asarinin, a natural lignan, has not previously been examined in the context of osteoclast differentiation. Here, we investigated the anti-osteoclastogenic effects of asarinin using RANKL-stimulated RAW264.7 cells. Asarinin significantly suppressed TRAP-positive multinucleated osteoclast formation. Mechanistically, asarinin selectively inhibited RANKL-induced phosphorylation of p38 and ERK MAPKs, leading to reduced c-Fos expression and inhibition of NFATc1 activation. In addition, asarinin disrupted actin ring formation in mature osteoclasts. Collectively, these findings identify asarinin as a pathway-selective inhibitor of osteoclast differentiation, acting through a mechanism consistent with modulation of the p38/ERK–c-Fos–NFATc1 signaling cascade while sparing parallel signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Osteoimmunology & Drug Discovery Research Group, Department of Biology, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 Daxue Road, Wenzhou 325060, China.
- Dorothy and George Hennings College of Science, Mathematics and Technology, Kean University, 1000 Morris Ave, Union, NJ 07083, USA.
- Department of Chemistry, College of Science, Mathematics and Technology, Wenzhou-Kean University, 88 Daxue Road, Wenzhou 325060, China.
- International Frontier Interdisciplinary Research Institute (IFIRI) of Wenzhou-Kean University, Wenzhou 325060, China.
- Wenzhou Municipal Key Laboratory for Applied Biomedical and Biopharmaceutical Informatics, Wenzhou-Kean University, Wenzhou 325060, China.
- Zhejiang Bioinformatics International Science and Technology Cooperation Center, Wenzhou-Kean University, Wenzhou 325060, China.
ORCID-Profile: Lifang Zhang, Mojtaba Tabandeh, Vishwa Deepak
Förderung
- Wenzhou-Kean University
- International Frontier Interdisciplinary Research Institute of Wenzhou-Kean University
- the WKU-ISRG
- WKU-ISRG grant
Zitieren
APA
Zhang, L., Xie, C., Bao, X., Li, X., Velez, H., Basit, F., Ding, Y., Tabandeh, M., & Deepak, V. (2026). Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis. International Journal of Molecular Sciences, 27(16), 7159. https://doi.org/10.3390/ijms27167159
Vancouver
Zhang L, Xie C, Bao X, Li X, Velez H, Basit F, et al. Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis. International Journal of Molecular Sciences. 2026;27(16):7159. doi:10.3390/ijms27167159
BibTeX
@article{Zhang2026,
author = {Zhang, Lifang and Xie, Chengxu and Bao, Xinyi and Li, Xiaohan and Velez, Heriberto and Basit, Farwa and Ding, Yili and Tabandeh, Mojtaba and Deepak, Vishwa},
title = {Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK–c-Fos–NFATc1 Axis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7159},
doi = {10.3390/ijms27167159}
}
EUVIMED